LIQUID HANDLING SYSTEMS MARKET ANALYSIS

Regional Analysis

Global Liquid Handling Systems Market Regional Insights:

• North America is the largest market for liquid handling systems, accounting for a market share of over 37.2% in 2023, the North America has dominated the liquid handling systems market over the past decade, primarily driven by increased R&D expenditure in the pharmaceutical and biotechnology industries. Growing demand for high-throughput screening and combination drugs will push pharmaceutical companies to invest in automated liquid handling equipment for improved efficiency in research workflows. Expansion of clinical diagnostics testing volume will also propel demand from hospitals and clinical laboratories.
• Europe is the second-largest market for liquid handling systems, accounting for a market share of over 26.5% in 2023 and the Europe liquid handling systems market is projected to witness significant growth over the forecast period driven by increasing R&D investment in pharmaceutical and biotechnology industries. Northwestern European countries such as Germany, U.K., and France dominate the region's market due to presence of major players and increasing global medical research investments. However, Central and Eastern European nations are expected to showcase higher growth rates during the assessment time frame buoyed by growing lab automation adoption across various end-users.
• Asia Pacific is the fastest-growing market for liquid handling systems, accounting for a market share of over 21.1% in 2023 this is due to the increases in pharmaceutical and biotech research and development expenditure across major Asia Pacific (APAC) economies. China and India are expected to see the fastest expansion in R&D expenditure which will boost demand for automated liquid handling systems. Increased regulatory approvals for new drug development are also supporting market growth. However, shortages of skilled lab technicians and high initial installation costs of liquid handling systems may restrain the market to some extent. Opportunities lie in expanding applications outside of core drug development into areas such as diagnostics, forensics, and academic research